Keymed Biosciences, Inc.'s total assets for Q4 2024 were ¥3.77B, a decrease of -1.02% from the previous quarter. HK:2162 total liabilities were ¥1.29B for the fiscal quarter, a 10.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.